Table 1. Summary of factors associated with post-liver transplant NAFLD.
Increased risk | Possible risk | Possible protection |
---|---|---|
Obesity | Sarcopenia | Everolimus |
T2DM | CNI therapy | |
Hyperlipidemia | Donor graft steatosis | |
PNPLA3 polymorphism | ||
Corticosteroid therapy | ||
Indications: NASH, ALD, HCV |